MAPS (Multidisciplinary Association for Psychedelic Studies)

Mentioned in 6 analyzed podcast episodes across 5 shows

Mentioned On

Today, Explained Making Sense with Sam Harris Psychedelics Today Extend Podcast with Darshan Shah, MD Decoded | Unlock The Secrets of Human Behavior, Emotion and Motivation

Episode Mentions

Today, Explained · May 18, 2026

How the right embraced psychedelics

“Rick Doblin heads MAPS, an organization promoting psychedelic research that has influenced Trump administration policy discussions”

Ibogaine legalization and Schedule 1 drug reclassificationPsychedelic therapy for PTSD and traumatic brain injury in veteransOpioid addiction treatment alternatives

View Analysis

Making Sense with Sam Harris · May 12, 2026

#475 — The Hard Problem of Consciousness

“Pioneer organization in restarting psychedelic research and advocacy, strategically building support among veterans groups and political figures”

Hard Problem of ConsciousnessNeural Correlates of ConsciousnessPsychedelic-Assisted Therapy

View Analysis

Psychedelics Today · May 8, 2026

PT 655 - Martha Hammel and Tasia Poinsatte - Aspen Psychedelic Symposium

“Izzy from MAPS mentioned as keynote speaker at the Aspen Psychedelic Symposium”

Aspen Psychedelic Symposium 2026 programming and speaker lineupColorado Natural Medicine Health Act implementation and regulationIbogaine policy development and Nagoya Protocol compliance

View Analysis

Extend Podcast with Darshan Shah, MD · Mar 10, 2026

145. Dr. Dave Rabin: HRV, Vagal Tone, and the Science of Safety for Performance and Mental Health

“Organization conducting Phase 2 MDMA-assisted therapy trials showing 67% PTSD remission rates”

Heart Rate Variability (HRV) as biomarker for resilience and longevityVagus nerve function and parasympathetic nervous system activationEustress vs. distress: good stress vs. harmful chronic stress

View Analysis

Decoded | Unlock The Secrets of Human Behavior, Emotion and Motivation · Jan 15, 2026

Why Most Mental Health Treatments Don’t Work with Dr. Dave Rabin

“Organization conducting rigorous double-blind randomized controlled trials on MDMA-assisted therapy showing 67% PTSD remission rates”

PTSD Treatment Resistance and Remission RatesVagus Nerve Stimulation vs. Modulation TechnologyMDMA-Assisted Psychotherapy Clinical Outcomes

View Analysis

Extend Podcast with Darshan Shah, MD · Dec 18, 2025

122. Dr. Mayim Bialik on Stress, Mental Health, and Human Connection

“Organization conducting clinical research on psilocybin-assisted therapy for PTSD”

Stress and nervous system regulation (sympathetic vs parasympathetic balance)Gut-brain-immune axis and microbiome healthChildhood trauma and intergenerational trauma

View Analysis